The Food and Drug Administration endorsed the IV drug, Leqembi, for patients with mild dementia and other symptoms caused by early Alzheimer’s disease.
Alzheimer’s disease
Posted inAmerican Journal, Coastal Journal, Lakes Region Weekly, Northern Forecaster, Portland Forecaster, Southern Forecaster, The Forecaster
Games with grandfather inspire new chess club for those with memory loss
The idea for the club came from a Cape Elizabeth student who played the game with her grandfather, who had dementia but “always remembered how to play chess.”
advertisement
Posted inHealth, Local & State
Sen. Collins spearheads efforts to fund Alzheimer’s research
A bipartisan group of senators is proposing to boost funding for research and prevention through 2035.
Posted inNews
FDA approves Alzheimer’s drug that modestly slows disease
The drug, Leqembi, is the first that’s been convincingly shown to slow the decline in memory and thinking that defines Alzheimer’s by targeting the disease’s underlying biology.
Posted inHealth, News
Drug slows Alzheimer’s but can it make a real difference?
New data shows an experimental Alzheimer’s drug modestly slowed the brain disease’s inevitable worsening.
Posted inMaine Voices, Opinion
Maine Voices: The long goodbye – my family, my father and Alzheimer’s
The disease’s progression tests our ties, but maybe a cure is in the pipeline so other families will not have to endure what we and many millions of others do each day.
Posted inTimes Record
Walk to End Alzheimer’s returns to downtown Brunswick Oct. 15
The annual Midcoast Area Walk to End Alzheimer’s starts with registration at 9 a.m. Saturday at the Maine Street mall and gazebo, with a welcome ceremony at 10 a.m. and walk start at 10:30 a.m.
Posted inHealth, Local & State
Gov. Mills launches program to give grants up to $2,000 to family caregivers
The $5.1 million program is for family caregivers of patients with disabilities, such as Alzheimer’s and dementia, who are being cared for at home.
Posted inHealth, News
Experimental Alzheimer’s drug slows cognitive decline in trial, firms say
Makers of the drug have already applied to the Food and Drug Administration for accelerated approval for lecanemab, based on earlier-stage data.
Posted inHealth
Even simple exercise may help aging brain, study hints
Stretching and balancing moves can be as beneficial as an aerobic workout.